GTAM
TEVA icon

Global Trust Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Global Trust Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20
Closed – – 422
2019
Q4 		$0 Sell
20
-168
-89% -$1.5K ﹤0.01% 422
2019
Q3 		$1K Hold
188
– – ﹤0.01% 352
2019
Q2 		$2K Hold
188
– – ﹤0.01% 361
2019
Q1 		$3K Hold
188
– – ﹤0.01% 318
2018
Q4 		$3K Hold
188
– – ﹤0.01% 334
2018
Q3 		$4K Hold
188
– – ﹤0.01% 357
2018
Q2 		$5K Hold
188
– – ﹤0.01% 336
2018
Q1 		$3K Hold
188
– – ﹤0.01% 341
2017
Q4 		$4K Buy
+188
New +$2.83K ﹤0.01% 353

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Global Trust Asset Management's TEVA Position: Q1 2020 in Review

Global Trust Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 20 shares.

Global Trust Asset Management first reported a position in TEVA in Q4 2017 and held it in 9 quarters. The position peaked at $5K in Q2 2018. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

  • Global Trust Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Global Trust Asset Management sold 20 Teva Pharmaceuticals shares in Q1 2020.
  • Global Trust Asset Management first reported a position in Teva Pharmaceuticals in Q4 2017 and held it in 9 quarters.
  • Global Trust Asset Management's Teva Pharmaceuticals position peaked at $5K in Q2 2018.
  • 459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Global Trust Asset Management's 13F filing for Q1 2020, filed 6 Apr 2020.